Biotech · Private company
Evolve Biologics
Track this companyFree. Adds Evolve Biologics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- 10% IGIVPhase 3 · Primary Immune Deficiency Diseases (PIDD)ClinicalTrials.gov · fetched Nov 12, 2026
- TBI 302Phase 1 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular CarcinomaPHASE1 · UNKNOWN · started Dec 1, 2019ClinicalTrials.gov NCT03908840 · fetched Nov 12, 2026
- Study of PlasmaCap IG in Adults and Children With PIDDPHASE3 · COMPLETED · started Sep 5, 2017ClinicalTrials.gov NCT03238079 · fetched Nov 12, 2026